COMPANY DESCRIPTION
Pioneer company of nanohybrids for industrial applications
Nano-H was created in December 2004 by a team of Lyon university researchers. This company is specialized in the development of innovative technologies for the manufacture of new materials based on hybrid nanoparticles.
Nano-H won the national competition for the creation of innovative technology companies organized by the Ministry of Research in 2004.
Since its creation, Nano-H's activities have focused on two main areas :
-
functional nanomaterials, in optics and tracers.
-
nanomaterials for biological applications, especially nanodrugs.
Nano-H is the originator of the first hybrid organic/inorganic theranostic drug : AGuIX
Today, Nano-H takes on the role of orchestrating the annual nano-hybrid congress, renowned as the
"Annual Conference of the Architects of Nano-hybrid Compounds: Toward Material and Biological Applications."
In addition, Nano-H engages in a fruitful partnership with the esteemed startup I2V, offering unparalleled preclinical trials on mice and rats, characterized by both favorable pricing and expeditious turnaround times.
ANALYTICAL AND MEDICAL STRATEGY
We offer customized research projects for the academic and industrial sectors. This activity is based on Nano-H's expertise and its ability to adapt its materials to the applications of its customers and partners.
Nano-h is also part of the IMITATE ANR :
Integrated Microsystems for In silico Modeling and in vitro assessment of nanoparticle TrAnsport & radioTherapy Efficacy
PUBLICATIONS
Nano-H has collaborated with many companies and academic laboratories in the framework of collaborative projects. It has participated in 17 ANR, European, or other projects as a co-developer or contractor.
Its teams and founding members have participated in more than a hundred scientific publications related to Nano-Hybrids.
